Large scale analysis of pediatric antiviral CD8+ T cell populations reveals sustained, functional and mature

Haruki Komatsu1, Ayano Inui, Tsuyoshi Sogo

  • 1Department of Pediatrics, National Defense Medical College, Saitama, Japan. haruki-komatsu@chive.ocn.ne.jp

Immunity & Ageing : I & A
|December 13, 2006
PubMed

Insights

Cytomegalovirus (CMV) infection triggers robust CD8+ T cell responses in children, maintaining high frequencies throughout life. Unlike adults, children do not show T cell "inflation," suggesting potential for early vaccine strategies.

Area of Science:

  • Immunology
  • Virology
  • Pediatrics

Background:

  • Cellular immunity is vital for controlling cytomegalovirus (CMV) infection.
  • Substantial CMV-specific T cells accumulate over a lifetime.
  • Pediatric T cell responses to CMV are not well understood.

Purpose of the Study:

  • To characterize the quantity and quality of T cell responses in pediatric populations against CMV.
  • To compare CMV-specific CD8+ T cell responses in children versus adults.

Main Methods:

  • Analyzed HLA typing and HLA-A2 antigen in 1036 individuals (ages 0-19 years) and 50 elderly individuals.
  • Measured frequencies, phenotype, and function of CD8+ T cells targeting two immunodominant CMV pp65 epitopes.
  • Compared T cell responses between pediatric and adult cohorts.

Main Results:

  • Consistently high frequencies of phenotypically mature CMV-specific CD8+ T cells were observed in children, including infants.
  • These CD8+ T cells maintained functionality across all age groups studied.
  • Evidence of memory T cell "inflation" was only observed in older adults, not children.

Conclusions:

  • CMV elicits strong CD8+ T cell responses in infants, with large pools maintained throughout childhood.
  • CMV shapes the CD8+ T cell compartment, but population-level increases are not seen in childhood/adulthood, contrasting with older adults.
  • Large-scale analysis of peptide-specific T cell responses in infants is feasible, supporting vaccine strategies for major pathogens in this age group.
Abstract